BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38485003)

  • 21. Comprehensive analysis of a widely pharmaceutical, furosemide, and its degradation products in aquatic systems: Occurrence, fate, and ecotoxicity.
    Sandré F; Moilleron R; Morin C; Garrigue-Antar L
    Environ Pollut; 2024 May; 348():123799. PubMed ID: 38527585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
    Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
    Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Removal of pharmaceutical contaminants from hospital wastewater using constructed wetlands: a review.
    Mumtaj ZA; Khan AR; Alsubih M; Aleya L; Khan RA; Khan S
    Environ Sci Pollut Res Int; 2024 Feb; 31(9):12856-12870. PubMed ID: 38277099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of occurrence, fate and removal of priority phthalate esters (PAEs) in wastewater and sewage sludge by advanced biological treatment, waste stabilization pond and constructed wetland.
    Nas B; Ateş H; Dolu T; Yel E; Argun ME; Koyuncu S; Kara M; Dinç S
    Chemosphere; 2022 May; 295():133864. PubMed ID: 35150704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceuticals and personal care products in water streams: Occurrence, detection, and removal by electrochemical advanced oxidation processes.
    Lozano I; Pérez-Guzmán CJ; Mora A; Mahlknecht J; Aguilar CL; Cervantes-Avilés P
    Sci Total Environ; 2022 Jun; 827():154348. PubMed ID: 35257780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative overview of advanced oxidation processes and biological approaches for the removal pharmaceuticals.
    Taoufik N; Boumya W; Achak M; Sillanpää M; Barka N
    J Environ Manage; 2021 Jun; 288():112404. PubMed ID: 33780817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of multiclass pharmaceutical active compounds (PhACs) in hospital WWTP influent and effluent samples by UHPLC-Orbitrap MS: Temporal variation, removals and environmental risk assessment.
    Kosma CI; Kapsi MG; Konstas PG; Trantopoulos EP; Boti VI; Konstantinou IK; Albanis TA
    Environ Res; 2020 Dec; 191():110152. PubMed ID: 32877707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Algae-mediated processes for the treatment of antiretroviral drugs in wastewater: Prospects and challenges.
    Reddy K; Renuka N; Kumari S; Bux F
    Chemosphere; 2021 Oct; 280():130674. PubMed ID: 34162077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna.
    Han GH; Hur HG; Kim SD
    Environ Toxicol Chem; 2006 Jan; 25(1):265-71. PubMed ID: 16494251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of pharmaceuticals, hazard assessment and ecotoxicological evaluation of wastewater treatment plants in Costa Rica.
    Ramírez-Morales D; Masís-Mora M; Montiel-Mora JR; Cambronero-Heinrichs JC; Briceño-Guevara S; Rojas-Sánchez CE; Méndez-Rivera M; Arias-Mora V; Tormo-Budowski R; Brenes-Alfaro L; Rodríguez-Rodríguez CE
    Sci Total Environ; 2020 Dec; 746():141200. PubMed ID: 32771760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced oxidation and biological integrated processes for pharmaceutical wastewater treatment: A review.
    Adeoye JB; Tan YH; Lau SY; Tan YY; Chiong T; Mubarak NM; Khalid M
    J Environ Manage; 2024 Feb; 353():120170. PubMed ID: 38308991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment.
    Luo Y; Guo W; Ngo HH; Nghiem LD; Hai FI; Zhang J; Liang S; Wang XC
    Sci Total Environ; 2014 Mar; 473-474():619-41. PubMed ID: 24394371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microplastic removal and management strategies for wastewater treatment plants.
    Ahmed SF; Islam N; Tasannum N; Mehjabin A; Momtahin A; Chowdhury AA; Almomani F; Mofijur M
    Chemosphere; 2024 Jan; 347():140648. PubMed ID: 37952815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
    Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
    Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal efficiency for emerging contaminants in a WWTP from Madrid (Spain) after secondary and tertiary treatment and environmental impact on the Manzanares River.
    Lopez FJ; Pitarch E; Botero-Coy AM; Fabregat-Safont D; Ibáñez M; Marin JM; Peruga A; Ontañón N; Martínez-Morcillo S; Olalla A; Valcárcel Y; Varó I; Hernández F
    Sci Total Environ; 2022 Mar; 812():152567. PubMed ID: 34952067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in microalgal mediated bioremediation systems for the removal of antibiotics and pharmaceuticals from wastewater.
    Chandel N; Ahuja V; Gurav R; Kumar V; Tyagi VK; Pugazhendhi A; Kumar G; Kumar D; Yang YH; Bhatia SK
    Sci Total Environ; 2022 Jun; 825():153895. PubMed ID: 35182616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical compound removal efficiency by a small constructed wetland located in south Brazil.
    De Vargas JPR; Bastos MC; Al Badany M; Gonzalez R; Wolff D; Santos DRD; Labanowski J
    Environ Sci Pollut Res Int; 2021 Jun; 28(24):30955-30974. PubMed ID: 33594565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant.
    Salgado R; Marques R; Noronha JP; Carvalho G; Oehmen A; Reis MA
    Environ Sci Pollut Res Int; 2012 Jun; 19(5):1818-27. PubMed ID: 22207237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of pharmaceuticals from wastewater by fungal treatment and reduction of hazard quotients.
    Lucas D; Barceló D; Rodriguez-Mozaz S
    Sci Total Environ; 2016 Nov; 571():909-15. PubMed ID: 27436780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.